Please enable JavaScript to continue using this application.

Compare $IRON vs $SLS | Chartloom

Compare

$IRON vs $SLS

Disc Medicine Inc · Sellas Life Sciences Group Inc

IRON

Disc Medicine Inc

SLS

Sellas Life Sciences Group Inc

Compare $IRON vs $SLS

Comparing Disc Medicine Inc and Sellas Life Sciences Group Inc

IRONDisc Medicine Inc

SLSSellas Life Sciences Group Inc

IRONDisc Medicine Inc

Market cap

$2.37B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-21.5%

52W performance

-11.7%

FCF yield

-8.3%

SLSSellas Life Sciences Group Inc

Market cap

$2.29B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

167.8%

52W performance

503.6%

FCF yield

-1.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IRON

SLS

Detailed metrics comparison

IRON

Disc Medicine Inc

SLS

Sellas Life Sciences Group Inc

Market Cap

IRON$2.37B

SLS$2.29B

Enterprise Value

IRON$2.33B

SLS$2.15B

Price

IRON$62.06

SLS$11.65

P/E Ratio

IRONN/A

SLSN/A

P/S Ratio

IRON0.00x

SLS817.53x

EV/Sales

IRON0.00x

SLS769.83x

EV/EBITDA

IRON0.00x

SLS0.00x

P/B Ratio

IRON3.84x

SLS17.22x

P/FCF Ratio

IRONN/A

SLSN/A

EV/FCF

IRON-11.80x

SLS-75.73x

PEG Ratio

IRONN/A

SLSN/A

Forward P/E (NTM)

IRONN/A

SLSN/A

Forward P/S (NTM)

IRONN/A

SLSN/A

Revenue (TTM)

IRON$0

SLS$0

Revenue Growth (YoY)

IRONN/A

SLSN/A

Forward Rev Growth

IRON300.5%

SLS144.9%

Gross Margin (TTM)

IRON0.0%

SLS93.1%

Operating Margin (TTM)

IRON0.0%

SLS0.0%

EBITDA Margin (TTM)

IRON0.0%

SLS0.0%

Net Margin (TTM)

IRON0.0%

SLS0.0%

FCF Margin (TTM)

IRONN/A

SLSN/A

Net Income (TTM)

IRON$-246M

SLS$-32M

FCF (TTM)

IRON$-198M

SLS$-28M

EPS (TTM)

IRON-$6.36

SLS-$0.17

ROE (TTM)

IRON-3717.0%

SLS-3591.0%

ROA (TTM)

IRON-3365.0%

SLS-3334.0%

ROIC (TTM)

IRON-3522.0%

SLS-3591.0%

Cash

IRON$99M

SLS$138M

Debt

IRON$59M

SLS$0

Net Cash/Debt

IRON$39M

SLS$138M

Current Ratio (TTM)

IRON24.14x

SLS18.83x

Quick Ratio (TTM)

IRON23.64x

SLS18.29x

Debt/Equity (TTM)

IRON0.09x

SLS0.00x

Debt/Assets (TTM)

IRON0.0%

SLS0.0%

Interest Coverage (TTM)

IRONN/A

SLSN/A

Net Debt/EBITDA (TTM)

IRON0.00x

SLS0.00x

Beta

IRON0.95

SLS2.68

52W Performance

IRON-11.7%

SLS503.6%

YTD Performance

IRON-21.5%

SLS167.8%

% from 52W High

IRON-37.6%

SLS-26.6%

% from 52W Low

IRON55.2%

SLS738.1%

Asset Turnover (TTM)

IRON0.00x

SLS0.09x

FCF Yield (TTM)

IRON-8.3%

SLS-1.2%

Earnings Yield (TTM)

IRON-10.4%

SLS-1.4%

Dividend Yield (TTM)

IRONN/A

SLSN/A

Rule of 40

IRON0.0

SLS0.0

EV/GP/RG

IRONN/A

SLSN/A

Ticker research

View IRON research View SLS research

Metric	IRON Disc Medicine Inc	SLS Sellas Life Sciences Group Inc
Market & Valuation
Market Cap	$2.37B	$2.29B
Enterprise Value	$2.33B	$2.15B
Price	$62.06	$11.65
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	817.53x
EV/Sales	0.00x	769.83x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.84x	17.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.80x	-75.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	300.5%	144.9%
Profitability
Gross Margin (TTM)	0.0%	93.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-246M	$-32M
FCF (TTM)	$-198M	$-28M
EPS (TTM)	-$6.36	-$0.17
ROE (TTM)	-3717.0%	-3591.0%
ROA (TTM)	-3365.0%	-3334.0%
ROIC (TTM)	-3522.0%	-3591.0%
Financial Health
Cash	$99M	$138M
Debt	$59M	$0
Net Cash/Debt	$39M	$138M
Current Ratio (TTM)	24.14x	18.83x
Quick Ratio (TTM)	23.64x	18.29x
Debt/Equity (TTM)	0.09x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.95	2.68
52W Performance	-11.7%	503.6%
YTD Performance	-21.5%	167.8%
% from 52W High	-37.6%	-26.6%
% from 52W Low	55.2%	738.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.09x
FCF Yield (TTM)	-8.3%	-1.2%
Earnings Yield (TTM)	-10.4%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IRON research	View SLS research

Valuation

P/S Ratio

IRON

0.00x

SLS

817.53x

EV/FCF

SLS

-75.73x

IRON

-11.80x

Growth & revenue

Forward Revenue Growth

IRON

300.5%

SLS

144.9%

Profitability & performance

Gross Margin

SLS

93.1%

IRON

0.0%

ROE

SLS

-3591.0%

IRON

-3717.0%

FCF Yield %

SLS

-1.2%

IRON

-8.3%

52-Week Performance

SLS

503.6%

IRON

-11.7%

Detailed metrics comparison

IRON

Disc Medicine Inc

SLS

Sellas Life Sciences Group Inc

Market Cap

IRON$2.37B

SLS$2.29B

Enterprise Value

IRON$2.33B

SLS$2.15B

Price

IRON$62.06

SLS$11.65

P/E Ratio

IRONN/A

SLSN/A

P/S Ratio

IRON0.00x

SLS817.53x

EV/Sales

IRON0.00x

SLS769.83x

EV/EBITDA

IRON0.00x

SLS0.00x

P/B Ratio

IRON3.84x

SLS17.22x

P/FCF Ratio

IRONN/A

SLSN/A

EV/FCF

IRON-11.80x

SLS-75.73x

PEG Ratio

IRONN/A

SLSN/A

Forward P/E (NTM)

IRONN/A

SLSN/A

Forward P/S (NTM)

IRONN/A

SLSN/A

Revenue (TTM)

IRON$0

SLS$0

Revenue Growth (YoY)

IRONN/A

SLSN/A

Forward Rev Growth

IRON300.5%

SLS144.9%

Gross Margin (TTM)

IRON0.0%

SLS93.1%

Operating Margin (TTM)

IRON0.0%

SLS0.0%

EBITDA Margin (TTM)

IRON0.0%

SLS0.0%

Net Margin (TTM)

IRON0.0%

SLS0.0%

FCF Margin (TTM)

IRONN/A

SLSN/A

Net Income (TTM)

IRON$-246M

SLS$-32M

FCF (TTM)

IRON$-198M

SLS$-28M

EPS (TTM)

IRON-$6.36

SLS-$0.17

ROE (TTM)

IRON-3717.0%

SLS-3591.0%

ROA (TTM)

IRON-3365.0%

SLS-3334.0%

ROIC (TTM)

IRON-3522.0%

SLS-3591.0%

Cash

IRON$99M

SLS$138M

Debt

IRON$59M

SLS$0

Net Cash/Debt

IRON$39M

SLS$138M

Current Ratio (TTM)

IRON24.14x

SLS18.83x

Quick Ratio (TTM)

IRON23.64x

SLS18.29x

Debt/Equity (TTM)

IRON0.09x

SLS0.00x

Debt/Assets (TTM)

IRON0.0%

SLS0.0%

Interest Coverage (TTM)

IRONN/A

SLSN/A

Net Debt/EBITDA (TTM)

IRON0.00x

SLS0.00x

Beta

IRON0.95

SLS2.68

52W Performance

IRON-11.7%

SLS503.6%

YTD Performance

IRON-21.5%

SLS167.8%

% from 52W High

IRON-37.6%

SLS-26.6%

% from 52W Low

IRON55.2%

SLS738.1%

Asset Turnover (TTM)

IRON0.00x

SLS0.09x

FCF Yield (TTM)

IRON-8.3%

SLS-1.2%

Earnings Yield (TTM)

IRON-10.4%

SLS-1.4%

Dividend Yield (TTM)

IRONN/A

SLSN/A

Rule of 40

IRON0.0

SLS0.0

EV/GP/RG

IRONN/A

SLSN/A

Ticker research

View IRON research View SLS research

Metric	IRON Disc Medicine Inc	SLS Sellas Life Sciences Group Inc
Market & Valuation
Market Cap	$2.37B	$2.29B
Enterprise Value	$2.33B	$2.15B
Price	$62.06	$11.65
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	817.53x
EV/Sales	0.00x	769.83x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.84x	17.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.80x	-75.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	300.5%	144.9%
Profitability
Gross Margin (TTM)	0.0%	93.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-246M	$-32M
FCF (TTM)	$-198M	$-28M
EPS (TTM)	-$6.36	-$0.17
ROE (TTM)	-3717.0%	-3591.0%
ROA (TTM)	-3365.0%	-3334.0%
ROIC (TTM)	-3522.0%	-3591.0%
Financial Health
Cash	$99M	$138M
Debt	$59M	$0
Net Cash/Debt	$39M	$138M
Current Ratio (TTM)	24.14x	18.83x
Quick Ratio (TTM)	23.64x	18.29x
Debt/Equity (TTM)	0.09x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.95	2.68
52W Performance	-11.7%	503.6%
YTD Performance	-21.5%	167.8%
% from 52W High	-37.6%	-26.6%
% from 52W Low	55.2%	738.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.09x
FCF Yield (TTM)	-8.3%	-1.2%
Earnings Yield (TTM)	-10.4%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IRON research	View SLS research